Lumexa Imaging Holdings, Inc.: Business Overview, Financials & Competitive Analysis
Lumexa Imaging Holdings, Inc. scores 7/10 on the AskCyborg Cyborg Score (Strong). Strong operational growth and strategic expansion position Lumexa to capitalize on demographic tailwinds and outpatient imaging trends despite near-term profitability challenges. Lumexa reported preliminary 2025 Adjusted EBITDA of $229.0M with higher advanced imaging volumes and strong PET growth, while system-wide total procedures reached 3,972,228 in 2025 with advanced.
What is Lumexa Imaging Holdings, Inc.'s industry? Lumexa Imaging Holdings, Inc. (lumexaimaging.com) operates in Diagnostic Imaging Services / Healthcare Facilities & Services. AskCyborg classifies Lumexa Imaging Holdings, Inc. under Diagnostic Imaging Services / Healthcare Facilities & Services in its company registry.
Lumexa Imaging is a nationwide provider of outpatient medical imaging with over 5,000 team members and more than 185 outpatient imaging centers across 13 states, conducting approximately 4 million outpatient scans in ...
Cyborg Score thesis
Strong operational growth and strategic expansion position Lumexa to capitalize on demographic tailwinds and outpatient imaging...
Read the full analyst-debate transcript →Get the Latest Lumexa Imaging Holdings, Inc. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeLumexa Imaging Holdings, Inc. Overview
Pro stress-test →Lumexa Imaging is a nationwide provider of outpatient medical imaging with over 5,000 team members and more than 185 outpatient imaging centers across 13 states, conducting approximately 4 million outpatient scans in 2024. The company recently completed its IPO in December 2025 and has emerged as one of the nation's largest diagnostic imaging providers.
Strategic Profile
Pro stress-test →The company offers a range of advanced imaging services including MRI, CT and PET scans, as well as routine diagnostic and screening imaging services like X-ray, ultrasound and mammography. Lumexa set a company record by opening nine de novo centers in 2025, demonstrating aggressive expansion and capitalizing on secular shifts toward outpatient imaging.
Competitive Landscape
Pro stress-test →As of September 30, 2025, Lumexa operated the second largest outpatient imaging center footprint in the United States. The company competes within the fragmented diagnostic imaging services market against national chains, hospital-based imaging departments, and independent imaging centers. Its scale, technology platform, and de novo expansion strategy provide competitive advantages.
Industry Context
Lumexa Imaging Holdings, Inc. operates in Diagnostic Imaging Services / Healthcare Facilities & Services.
Key facts
Founded: 2012 · Headquarters: Raleigh, NC · Employees: 5,000 · Market cap: $1.76B